Freenome Raises $254M For Early Cancer Detection Tests
By Yeji Jesse Lee · February 15, 2024, 7:15 PM EST
Cancer-focused biotechnology company Freenome said Thursday it has raised $254 million from investors to advance cancer detection tests in its pipeline....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login